Introduction

In cancer biology, viruses possess a foremost role over the past two decades, and especially, the tumor viruses encompassing RNA and DNA with the fundamental contributions are highly responsible1. Numerous oncogenes carried by retroviruses that were derived from the cellular genes are involved in the signaling and control of cell growth. These oncogenes from the viral origin are requisite for the replication and cell transformation2. The organization of the genome in retroviruses differentiates the representations of the simple and complex viruses. Retroviruses which does not possess viral oncogenes like avian leukosis virus and mouse mammary tumor virus induce tumors in animals2. Further, the virus which is responsible for the development of malignancies with expanded latency in relation towards the environmental and host associated cooperating events exists. The oncogenicity of the virus and the mode of infection discriminate the nature from other carcinogenic agents. Better insights on the pathogenesis of viral infection and host responses are very important in understanding the cancers in detail. Oncogenic viruses belong to diverse families and employ varied mechanism for the development of cancer3. Martin and Gutkind states that the Hepatitis B virus (HBV), Human T-cell lymphotropic virus (HTLV), Epstein-Barr virus (EBV), Human papillomavirus (HPV), Hepatitis C virus (HCV), and Kaposi’s associated sarcoma virus (KSHV) contributes towards 15% of the human cancer4.

Italian physicist Ciuffo identified the etiology of warts in human around 1907 and identified the link with HPV in the 1970s. The infections caused by HPV in the cervix lead to cervical malignancy and other related warts. These viruses are non-enveloped double-stranded DNA viruses constituting triple segments namely the late, early and genomic regions5. The most common second malignant tumour that threatens the health of female all over the world is cervical cancer. The persistent infection caused by the human papillomavirus is the necessary cause of cervical cancer6. Further, different types of HPV have been characterized based on the ability to promote the proliferation of infected cells leading to cell transformation as low, intermediate and high-risk human papillomaviruses3,7. The HPV types 11, 6, 42, 40, 44, 43, 54, and 53 are intended to be low risk due to their involvement in the formation of benign warts whereas the HPV types 31, 35, 33 and 52 are identified to be the intermediate risk since it is responsible for mild and severe lesions. The HPV types 16, 18, 39 and 45 cause malignant transformation through their directing features towards the tumor suppressor proteins8,9. These viruses infect the keratinocyte, germ layers of the mucous membranes and skin. Also, the HPV infection is comparable among the different tissues which contaminate the basal layer of the cervix and enters the tonsillar epithelium divulging the crypt cells10,11. The genome of HPV is circular with 8 kbp which encodes major proteins namely the E1, E2, E4, E5, E6, E7, L1 and L2 in the early and late region. The proteins in the early region are responsible for the replication and transcription of genome and apoptosis control, immune modulation and modification in the structure whereas the proteins in the late region are responsible for the development of capsid proteins12. The early proteins E6 and E7 were observed to be oncogenic which depicts the major role in cell line transformation and regulation of the stability in chromosomes. These oncoproteins were responsible for their association with the tumor suppressors p53 and pRB proteins which are involved in the inactivation of the suppression ability of tumor leading to the formation of cancer12,13. E7 oncoprotein is strongly necessary for the lifecycle of virus and the development of cancer from the benign stage to invasive cancer. This oncoprotein E7 acts as the regulator of transcription and also suppresses numerous other genes which are regulated through the interferon and Nuclear Factor Kappa B (NF-kB) pathways which results in enabling the evasion of the immunity14. HPV E7 is termed to be the phosphoprotein whereas the process of phosphorylation is thought to be important for the function and regulation15.

In general, it is clearly evident that the treatment for cancer involves surgery, radiotherapy and chemotherapy depending on the phase and position of the tumor. Numerous anti-cancer drugs affect the normal cells that are divided rapidly under normal circumstances and cause serious side effects16. Hence, the identification of potent anticancer agents with fewer side effects is highly essential in the recent period. It is evident from the studies that the phytochemicals obtained from the ethnobotanically active plants that hinders the carcinogenic processes and will be useful for the treatment of cancer with minimal side effects17. They are classified into phenols, terpenoids, alkaloids and flavonols. Also, they possess beneficial roles like prevention of cancer, diabetes, antiviral and antimicrobial activities18. Generally, phytochemicals were in use from the ancient period by millions of people which arbitrate its positive health benefits by disturbing the affected molecular targets like genes19.

International Union for Conservation of Nature (IUCN) and the World Wildlife Fund has reported the availability of 80,000 flowering plant species for medicinal purposes20. Cremanthodium humile, Zingiber officinale, Cordyceps pruinosa, Ficus hirta, Mangifera indica, Nigella sativa, Corallina pilulifera, Citrus grandis, Cassia tora, Crocus sativa, Pinus massoniana, Pinellia pedatisecta, Dutchesnea indica, Solanum nigrum, Triticum aestivum, Cinnamomum cassia, Artemisia afra, Argimonia eupatoria, Pterocarpus santalinus and Phaseolus vulgaris are some of the essential medicinal plants in Indian traditional medicines. These plants possess various medicinal activities and especially they were reported to treat cervical cancer21,22,23,24,25,26,27,28,29,30. Despite the noteworthy role of phytochemicals from the ethnobotanical plants, the mechanism of action and their momentous immune-responsive human targets that involve various biological function, need to be elucidated strongly.

Our study endeavored to identify the activity of bioactive compounds and the mechanism of immunological features from the plant species M. indica, N. sativa, Z. officinale, C.grandis, Ziziphus jujube, Z. mauritiana and C.cassia against the cervical cancer. The involvement of immune- responsive genes which could be the reason for developing cervical cancer with their molecular cross-talks can be explored in this holistic study. Along with this, we attempted to explore the closely related genes with cervical cancer and the phytochemicals for the accomplishment of immunobiological activity. Advancements in the systems pharmacology and analytical tools like immuno-transcriptomics and interactome analysis help us to disclose the molecular interactions of phytochemicals for the treatment of harmful infection by viruses like HPV. Thus, our study divulges information concerning the immunological mechanism of phytochemicals and their pharmacological properties. The profiling with the immuno-transcriptomic data uncovers the differentially expressed genes associated with cervical cancer. Subsequently novel bioactive compounds with indispensable pharmacological activities are filtered out and these compounds that directly targets the human immune responsive genes of different functions are identified. Further, the immunological targets of cancer were then introduced to some specific database to discover the immunological mechanisms and the signaling pathways of bioactive compounds from the ethnobotanical plants. We assure that these explorations of the immunological mechanisms of the bioactive compounds will extensively endorse the expansion of novel drugs for the treatment of cervical cancer and other related cancers in near future.

Materials and methods

The systems pharmacology and the multi-omics approaches have been incorporated together to unravel the significant curative efficacy of potential therapeutic phytocompounds from natural plants to combat cervical cancer caused by HPV. These approaches consist of target mining and functional enrichment analysis to identify the phytocompounds used in the treatment of cervical cancer caused by HPV. Further, the systemic network construction and analysis to demonstrate the molecular machinery of phytocompounds extracted from the medicinal plants in treating cervical cancer is characterized in this pilot study. Further, the gene ontology and STRING analysis for HPV immune-responsive genes paves way for the diverse biological pathway analysis. This also helps in reveling the functional mode of key players in multiple nodes from the immunological pathway level19.

Mining of immune responsive genes of human transcriptome related to cervical cancer

The human transcriptomic datasets of cervical cancer cases were collected from the Array express database (https://www.ebi.ac.uk/arrayexpress/) with the ID: E-GEOD-39001 and E-GEOD-4684231 which encodes the affymetrix data. This data has been manually curated using excel Microsoft. Upon completion of the curation, the transcriptomic datasets was then imported into the Network Analyst 3.0. database (https://www.networkanalyst.ca/) especially to the Gene expression table to check the total number of genes32. The dataset is generally saved in the .txt file format which is plotted in the excel file with the microarray data intensities corresponding to the immune responsive genes of healthy controls and cancer patients. These data are depicted in the time series of columns and rows in the excel data format as sample and class. Followed by the incorporation of the dataset, normalization and filtering is carried out for making certain that the distribution of expression is comparable across the inclusive experiments and to remove the inconsistent data, respectively. Further, the differential gene expression analysis is carried out to witness the significant immune genes which are responsive through the Limma statistical model with the adjusted P-value less than 0.05 along with the representation of 1.0 as Log2 fold change value. The identified genes were further studied for the over representation analysis (ORA) functional enrichment along with the tissue-specific interactions through the inbuilt databases in Network Analyst 3.0. In order to make the results more clear, the probe set ID has been referred through the BioGPS database (http://biogps.org/dataset/) and the gene name was confirmed32 and provided in Supplementary Table S1.

Pharmacologically active phytocompounds

Exhaustive information on the pharmacologically active molecules from the plants M. indica, N. sativa, Z. officinale, C. grandis, Z. jujube, Z. mauritiana and C. cassia were retrieved from the web sources and literature22,23,24,25,26,27,28,29,30,33. List of the active compounds from the natural medicinal plants with their abbreviations were given in Table 1. The information like the canonical SMILES of the compounds was retrieved from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/)34 are also provided in Table 1. The identified compounds from the medicinal plants were searched against the Homo sapiens in SwissTargetPrediction tool (http://swisstargetprediction.ch/index.php) in order to retrieve the human targets especially the immune responsive genes35.

Table 1 List of Compounds with its Abbreviations & SMILES.
Full size table

Compound target network (CTN) construction and features of human targets

The construction of the CTN illuminates the multi-target therapeutic features of the pharmacologically active plant compounds. In this construction, we observed, the interaction between the human immune-responsive genes and the phytocompounds representing the interconnection which is visualized through the Cytoscape v3.8.0. In the obtained interactome, the node depicts the compounds and targets whereas the edge denotes the molecular interaction between the compounds and targets36. The significant 35 immune responsive genes/targets obtained from the literature and CTN analysis were used for the retrieval of molecular features like official Gene Symbol with the name, position of the target, chromosome numbers and orthologs of the differentially expressed immune responsive genes from the NCBI-gene database (https://www.ncbi.nlm.nih.gov/gene) and The Human Protein Atlas (https://www.proteinatlas.org/)19,37.

Pharmacological features of the compounds

The compounds with the respective canonical SMILES were subjected to the Molinspiration online tool (https://molinspiration.com/) in order to obtain significant molecular features of the phytocompounds. Along with this the bioactive score for the vital targets such as the GPCR ligand activity, protease inhibitor activity (Pi), Kinase Inhibitor activity (Ki) and number of violations (nVio) were predicted38,39,40.

Gene ontology enrichment analysis

The genes which are differentially expressed with the encoding gene symbols were uploaded to the GOnet (https://tools.dice-database.org/GOnet/) and Metascape (https://metascape.org/gp/index.html#/main/step1) databases in order to attain the ontology against the humans with the significant threshold of q-value which is greater than 0.05. The immune-responsive genes were pigeonholed with the molecular function and biological process based on the functional enrichment classification of the database35.

Construction of protein–protein interaction (PPI) Network associated with HPV 16 E7 and other cancer associated proteins

The cellular machinery of the proteins is formed based on the interactions made by the proteins. Recognition of the PPI perseveres to be one of the foremost determinations in modern biology as well as the improvement of protein therapeutics41. In our study, we attempted to identify the interactions between the oncoprotein of E7 and the dominated therapeutic proteins of human. The STRING database (https://string-db.org/) is used for the identification of the human proteins interacting with the obtained immune-responsive genes by providing the input manually obtained from the CTN42. The STRING database depicts the interactions between proteins which compasses direct interaction physically and the indirect correlation representing the functional aspects of the protein43. The information obtained from the database regarding the PPI is curated from the experimental data, prediction from the genomic features, text mining from the scientific articles and from various database44. This database provides the score based on the weight and impact of the interactions45. The PPI network of E7 oncoprotein of HPV with the confidence score of greater or equal to 0.7 was retrieved from STRING Viruses v10.5 (http://viruses.string-db.org/). These proteins interacting with E7 were imported to the cytoscape v3.8.0 software for better visualization36. The STRING Viruses generated the PPI network with the query as E7 oncoprotein in the database providing the direct interactions with the imputed protein, consisting of all the proteins and interactions between them43.

Results

Immune responsive genes from Meta-analysis of human immunotranscritpome

The transcriptomics dataset contains 8353 immune responsive genes which are diversified into 59 samples out of which 3680 genes were commonly found in the meta differential expression depicted in Fig. 1. Figure 1 states that, immune responsive genes that are up, down and non-significantly expressed. Followed by the interactive volcano plot, heat map profiling revealed that 384 immune responsive genes were expressed differentially in cervical cancer cases during various time periods when compared with the healthy controls which are clearly evident in Supplementary Fig. 1. The genes that are up and down regulated among the 384 genes were listed in Supplementary Table S2. The differentially expressed genes are visualized through the tissue specific PPI in the tissue type whole blood represented in Fig. 2. This network encompasses 4184 nodes and 8064 edges. Further, the pathway-based ORA enrichment network showed involvement in various biological pathways which is represented in Fig. 3.

Figure 1
figure 1

Volcano plot of the differential gene expression of immune genes of human. The scattered points indicate the up and down regulated and non-significant genes based on the threshold applied. Red spheres represent up regulation, blue spheres represent the down regulation and black spheres represent non-significant genes.

Full size image
Figure 2
figure 2

Tissue-specific PPI network for the differentially expressed genes. The green color represents the differentially expressed genes and the pink color spheres represent the interaction with various human immune responsive genes.

Full size image
Figure 3
figure 3

Enrichment network analysis observed through Network Analyst tool representing the pathways involved in differentially expressed genes.

Full size image

Retrieval of information regarding phytocompounds

A total of 87 molecules were retrieved through the literature and employed as a query in the PubChem database to fetch the canonical SMILES which are represented in Table 1 along with the abbreviations. The abbreviations mentioned were further used during the CTN construction. The obtained information about the compound was used further for the biomolecular analyses.

Pharmacologically active compounds and its interaction with human targets

The active phytocompounds that direct towards the human immune receptors were computed through the SwissTargetPrediction tool. Among the 87 compounds, 79 compounds were appreciably targeting 35 out of the 384 human immune-responsive and literature-retrieved receptors/genes that are differentially expressed between healthy and cancer cases. The comprehensive list of the phytocompounds and the equivalent interaction with the human immune responsive genes are provided in Table 2.

Table 2 Compounds and the respective human immune genes.
Full size table

CTN analysis

The CTN based cross talks between the 79 active compounds and 35 significant immune-responsive genes were depicted in Fig. 4. This analysis discloses the multi target strategy which is noteworthy feature of phytocompounds. The detailed information on the connection between the phytocompounds and the immune-responsive genes revealed the therapeutic ability of the bioactive molecules present in the Indian herbal plants such as M. indica, N. sativa, Z. officinale, C. grandis, Z. jujube, Z. mauritiana and C. cassia for combating cervical cancer caused by HPV infection through the transduction and modulating the signals of possible immune responsive genes.

Figure 4
figure 4

Visualization of CTN. Red color represents the immune responsive genes and green color represents the compound and blue color represents the tumor suppressor gene targeted by HPV.

Full size image

Properties of the human immune responsive genes

A total of 35 immune responsive genes have been targeted by 79 phytocompounds. The corresponding information on the immune receptors namely chromosome number, the full name of the genes, physical position and the orthologs details were obtained and provided in Table 3. This information paves way for the delineation of the detailed molecular function. Further, the pictorial representation of the significant gene and its involvement in various biological pathways were presented in Supplementary Fig. S2.

Table 3 Molecular attributes of the identified thirty-five human immune responsive genes.
Full size table

Gene ontology enrichment analysis

The molecular features of the considerable HPV infected cervical cancer immune responsive genes interacting with compounds were further analyzed with the Metascape which revealed the involvement of these immune genes in different molecular functions and biological processes. The targeted immune-responsive genes and the corresponding proteins were attributed to be involved in the crucial biological regulation of signal transduction, cell population proliferation, cellular metabolic processes, proteolysis, cell communication, apoptosis, response to stress, catabolic process and oxidative process. These processes of biological regulation with the 35 immune genes were strongly evident in Fig. 5.

Figure 5
figure 5

Representation of biological processes involved in the compound targeted thirty-five immune-responsive genes. The Orange color represents the immune targets and the green color represents the diverse biological processes.

Full size image

The Molecular functions of the selected 35 immune genes targeted by compounds were represented in Supplementary Fig. S3 stating that the immune targets are responsible for catalytic activity and the histone deacetylases binding. Followed by the molecular function, the enrichment network analysis carried out with the Metascape database is represented in Supplementary Fig. S4 stating the involvement in various biological pathways. The histogram corresponding to the enriched pathways in relation to the identified 35 genes was represented in Fig. 6 and differentiated based on the cluster ID with saturated colors. Further, the 35 genes were analyzed for the tissue-specific PPI observed for the whole blood tissue type. These interactions are depicted in Fig. 7.

Figure 6
figure 6

Histogram of Gene Ontology enrichment analysis corresponding to the P-value.

Full size image
Figure 7
figure 7

Tissue specific PPI obtained from Network Analyst. The pink colour in the image represents the significant immune responsive genes whereas the green color represents the interacting partners present in the human whole blood tissue.

Full size image

Molecular interactome analysis

A total of 35 genes including the cervical cancer immune genes retrieved from the compound network analysis and the literature reported which is differentially expressed between the healthy and the affected cases demonstrated the molecular cross-talks. The interactome possessess 75 nodes and 1101 edges represented in the Fig. 8. The average nodal degree of the immune responsive genes analyzed for the interactome is 29.4 in the closely connected immune proteins/genes. The enrichment score of the PPI for the immune responsive genes possesses p-value score of < 1.0e.16. These interactions also showed the complexity and functionalities of the cervical cancer responsive immune genes provided the potential targets for therapy against cancer. Additionally, the immune-responsive genes that interact with the HPV E7 obtained from the transcriptomic data were also identified for the molecular interaction between various human proteins which is represented in Fig. 9. This study clearly indicates that HPV E7 interacts with various cancer target proteins and represents those human proteins to be a potential target for drug discovery.

Figure 8
figure 8

Immune targets and the molecular interactions of the cervical cancer immune target.

Full size image
Figure 9
figure 9

Molecular interactions between HPV E7 oncoprotein and the human proteins involved in cervical cancer.

Full size image

Pharmacological features of the phytocompounds

The phytocompounds obtained from the literature reported for various biologically active plants have been calculated for their pharmacological properties such as the GPCR, Pi, Ki, Ncr, Ei, nVio which are represented in Table 4. The nVio and Ei has been considered to be significant with a threshold of above 0.5 feature score. Around 30 compounds are considered to be more efficacious that can be used further for the treatment of cervical cancer. The pharmacological features such as GPCR, Pi, Ki, Ncr, Ei, nVio influences the oral bioavailability, solubility and permeability of drug. These features were predicted through the experimentally validated computational approaches in accordance with the Rule of 5 (Ro5) drug discovery.

Table 4 Pharmacological features of the retrieved Phytocompounds.
Full size table

Discussion

Cancer has been represented to be the most widespread cause of mortality worldwide which leads to millions of deaths every year. This has been caused by various infections by different microorganisms among which viral infections catch hold of 20 percent importance and represent a significant function in the development of malignant and benign tumors46. These viruses contain various genes and proteins which possess oncogenic properties facilitating the various stages of carcinogenesis. One of the oncogenic viruses is the HPV which is involved in the infection through sexual transmission and causes cervical cancer47. Reports have witnessed stating that the oncoproteins of HPV interact with known and unknown cellular factors which are highly responsible for the development of cancerous lesions42,48.

Numerous drugs and vaccines are reported for the treatment of cervical cancer but the ineffectiveness of the anti-HPV drugs to medicate the harmful infection provoked us to identify the novel compounds that are effective in the control and treatment of the cancerous growth in humans. Alongside, the use of traditional medicines is known for decades in the treatment of various diseases in this world through the ancient medical practices49. Even though, the chemical composition of the medicinal plants has been obtained for the flawless drug development, this aspect is not confident enough due to the higher insolence of chemical entities and the functional aspects of the drug statute33,50. Researchers have reported that traditional medicines were proven to be effective to treat the infections and diseases caused by viruses like HIV, measles, hepatitis, coxsackievirus and HPV50. These observations on the viral oncoproteins and the role of plant compounds provided more insights into the understanding of the interaction with the human physiological system through the control of molecular cross-talks between the key elements in the immunological aspects. Further, the exact mechanism of the immune responsive targets and the impression of herbal medicines to treat viral infections is inadequate still35. With this as pilot information, we presented the immuno-transcriptomics and systems pharmacology strategies to unravel the immune targets of HPV and the associated signaling pathways along with the pharmacological roles of M. indica, N. sativa, Z officinale, C. grandis, Z. jujube, Z. mauritiana and C. cassia derived bioactive compounds for the treatment of HPV related cancerous growth at molecular level. Additionally, the information on the bioactive molecules derived from the natural plants for the treatment of viral disease provides vital information on therapeutics.

Our study is mainly focused on the identification and understanding of the pattern related to the gene expression of the host which is responsible for cervical cancer. Our investigation lies with the performance of the immuno-transcriptomics profiling between the infected and healthy controls with the transcriptomics dataset available in the public databases. These datasets were further processed with the Network Analyst 3.0 which helps in the retrieval of heatmap representing the intensities of microarray in cervical cancer immune genes. Based on this analysis, a total of 384 immune responsive genes between the healthy and infected patients were obtained with the intensity values. Further, these genes were selected for the successive analysis of the PPI. On the other hand, PubChem and other omics databases help in identifying 87 phytocompounds that are responsible for treating cervical cancer. Among the 87 phytocompounds, 79 compounds interacted with the 35 differentially expressed cervical cancer associated immune genes through drug targeting. The compounds that interact with the immune responsive genes were represented in Table 2 which shows that only 35 immune genes are involved in the process of drug targeting among the 87 phytocompounds. Remarkably, the predicted immune genes which are involved in the different biological activities against cervical cancer has been identified and some of the genes obtained from network analyst are not reported till date which exhibits the capability of SwissTargetPrediction and the gene ontology enrichment evaluation methods. Further, the ORA functional enrichment of the identified genes was demarcated with the help of Metascape. The analysis of the compounds that target the human genes which are expressed differentially highlights the role of 35 genes among the identified 384 genes and the literature reported receptors. The immune-responsive genes PTPN14, CDK2, HDAC9, MMP2, AURKA, PARP1 and GRIA depicts their role in most of the diseases targeting humans among the highlighted 35 components. The genes CDK2, HDAC9 and PTPN14 interact commonly with the phytocompounds that target the immune responsive and also with the HPV E7 oncoprotein which is strongly evident in Fig. 9. For instance, PTPN14 (Protein Tyrosine Phosphatase Non-Receptor Type 14) is the potential tumor suppressor which owns its involvement in the linkage to the control of Hippo and the Wnt/beta-catenin signaling pathways. Herein, we understood that the cross-talk between HPV E7 and PTPN14 might be the important reason for immune-pathological expression of cervical cancer51. The genes which have been commonly targeted by various phytocompounds are significantly playing a noteworthy role in different viral infections and are also responsible for other cancers/diseases.

The correlation between the host immune response to catalytic activity and the histone deacetylases binding is identified through the classification of molecular functions. The obtained results revealed that, the immune response between infections and cervical cancer is highly significant at the biological level. As per our earlier discussion, the role of PTPN14, CDK2 and HDAC9 in tumor suppression and the interaction with HPV E7 oncoprotein is observed stating that these targets can be potential druggable targets for cervical cancer. Additionally, functional enrichment and the gene ontology revealed its strong relation to apoptosis and other pathways in cancer. The molecular interactome analysis between the viral oncoprotein and the components of human immune response demonstrates the critical capability of viral replication to dodge the immunological responses. The compound target network analysis revealed that the retrieved 79 among 87 compounds strongly bind with the identified 35 compounds representing its ability to inhibit the progression of any diseases. Further, the cytoscape analysis revealed the interaction between the phytocompounds and the human immune genes which is the essential identification of this study. This study unveils the diversified mechanism of the compounds and the plausible mode of action towards assorted targets involved in cancer. These inferences help us to put forth the curative effects and promote the use of traditional medicines that leads to make novel avenues in the field of drug discovery and development. Further, it impacts the people’s lives by providing the drugs at low cost.

Conclusion

The results from our study reveals that the Indian traditional phytocompounds including a variety of medicinal values exhibits the expanded immunological stimulants to treat cervical cancer caused by the infection of HPV E7. The research on the traditional Indian medical plants notably on M. indica, N. sativa, Z. officinale, C. grandis, Z.jujube, Z. mauritiana and C. cassia is not explored completely. Radically, our result on the phytocompounds with the pharmacological properties represents the interaction with the human immune responsive genes along with their role in various biological processes and function. These studies overlay the groundwork for the aperture of advanced biological research on different types of cancer with the combination of traditional medicines. This study identified the several crucial aspects of the host immune response towards the infection of HPV E7 oncoprotein. The identified immune responsive genes and the corresponding signaling pathways help in unraveling the pathogenesis of cervical cancer. Also, these analyses help in the characterization of the immuno-pathology of the HPV E7 infection. Our study is mainly focused on the conjecturing the use of phytocompounds in combination with other components may provide synergistic effects which may lead to further development of new anti-HPV or anti-cancer drugs. Additionally, the molecular interactome analysis reveals that thirty-eight immune responsive genes can be considered the effective druggable targets for the treatment of various cancer and other diseases. On the whole, this comprehensive study behaves as the stage to improve the understanding of the immunological behavior of the HPV E7 oncoprotein which also provides the widespread knowledge in executing the intrusion approach.